slider

Brands Insyte-N™ Autoguard™

Peripheral IV Catheter Insyte-N™ Autoguard™ 24 Gauge 0.56 Inch BD Vialon Winged Hub Non Blood Co ... Read more

Product # : 413524 Class : MCKSN Distributor : RELIANCE INC Category : IV Catheters Availability : Please contact customer service at info@RxReliance.com to check availability.
Non-Stock Item Information : Any reason may apply
  • This item ships directly from the manufacturer. Additional shipping charges may apply.
  • As a special order from the supplier, the approximate delivery time is 2-4 weeks.
  • For equipment such as beds, lifts, etc., a freight code is required. Please reach out to us to get the code.

$0.00

Product Notices : This product may be non-returnable and/or require additional restocking fee.
Product Varient

Product Specifications

Product No. # 413524
Manufacturer # 381511
Brand Insyte-N™ Autoguard™
Manufacturer BD
Country of Origin United States
Application Peripheral IV Catheter
Sterility Sterile
Sterility Sterile
Shipping Width 8
Shipping Height 9.6
Shipping Depth 11
Dimension UOM IC
Shipping Weight 4.94
Weight UOM LB
QTY_Per_Sell 200
Sterility Sterile
Usage Disposable
Simply_Medical_Category IV Catheters
Catheter Length 0.56 Inch
Catheter Material BD Vialon
Color Code Yellow
FlowRate 20 mL / min
Gauge 24 Gauge
Hub Material Plastic Hub
Hub Type Winged Hub
Needle_Point_Style Notched Needle
Number_of_Ports Without Port
Port_Type Without Port
Tubing_Diameter 0.521 mm ID
Supply_Manager_Category IV Catheters
Supply_Manager_Hierarchy IV Therapy>IV Catheters>Peripheral IV Catheter
Legend_Code Yes
Stock_Status NonStock
Velocity Slow Selling
GTIN 50382903815116
Country of Origin United States
Other Popular Suggestions
Features
  • Autoguard™ Needle Shielding DeviceStabilizing wings provide a large surface area for taping down the catheter improving catheter securement
  • With the push of a button, the needle instantly retracts reducing the risk of accidental needle stick injuries
  • BD Vialon™, a unique proprietary biomaterial, has been proven to enhance clinical and economic outcomes
  • Reduces IV restarts due to reduced complications
  • Increases the ease of penetration